Loading...

Lee Daniel Gibbs

Title(s)Postdoctoral Scholar - Research Associate
Address1450 Biggy Street
Health Sciences Campus
Los Angeles CA 90089
Emailleedanig@usc.edu
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Xavier University of Louisiana, New Orleans, LAB.S. 05/2011Biology
    University of North Texas Health Science Center, Fort Worth, TXPh.D. 05/2017Biomedical Sciences
    Collapse Awards and Honors
    American Association for Cancer Research2020AACR NextGen Star
    American Association for Cancer Research2019AACR Minority Scholar in Cancer Research Award

    Collapse Overview 
    Collapse Overview
    Dr. Lee D. Gibbs is a postdoctoral research fellow in the Department of Translational Genomics at Keck School of Medicine of University of Southern California under the mentorship and guidance of Dr. John D. Carpten. He works with a multi-disciplinary team to evaluate genomic alterations that are inherited and acquired during tumor development and to understand the clinical significance of these events. His research focuses on using novel genomic sequencing technologies to reveal the unexplored landscape of tumor heterogeneity spatially and at a single cell resolution. These technologies will enable the design of precise and personalized therapies. In addition, his research focuses on the discovery and validation of biomarkers and therapeutic targets in rare and aggressive cancers that affect minorities and medically underserved populations. His goal is to evaluate the functional significance of these genomic events and their potential to determine prognosis, diagnosis, and therapeutic response.

    Collapse Research 
    Collapse Research Activities and Funding
    USC Provost’s Postdoctoral Scholar Research Grant
    USC Provost’s Postdoctoral Scholar Research Grant Jan 7, 2019 - Jan 7, 2020
    Role: Principal Investigator
    USC Provost’s Scholars Program for Faculty Diversity
    University of Southern California Office of the Provost Sep 30, 2017 - Sep 30, 2019
    Role: Provost's Research Scholar
    Role Description: This program enhances the diversity of postdoctoral scholars at the university and builds a pool of exceptional underrepresented minority candidates for the next generation of faculty across higher education. As a scholar, I will link the expertise of USC faculty and doctoral students with the knowledge and unique experience gained through my research and scholarship.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis. Breast Cancer Res. 2020 Mar 23; 22(1):31. Chaudhary P, Gibbs LD, Maji S, Lewis CM, Suzuki S, Vishwanatha JK. PMID: 32293512.
      View in: PubMed   Mentions:    Fields:    
    2. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis. Breast Cancer Res. 2020 01 28; 22(1):11. Chaudhary P, Gibbs LD, Maji S, Lewis CM, Suzuki S, Vishwanatha JK. PMID: 31992335.
      View in: PubMed   Mentions: 1     Fields:    
    3. ANXA2 expression in African American triple-negative breast cancer patients. Breast Cancer Res Treat. 2019 Feb; 174(1):113-120. Gibbs LD, Chaudhary P, Mansheim K, Hare RJ, Mantsch RA, Vishwanatha JK. PMID: 30478786.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer. Oncotarget. 2018 Jan 05; 9(2):2697-2704. Gibbs LD, Vishwanatha JK. PMID: 29416802.
      View in: PubMed   Mentions: 2     Fields:    
    5. MIEN1 is tightly regulated by SINE Alu methylation in its promoter. Oncotarget. 2016 Oct 04; 7(40):65307-65319. Rajendiran S, Gibbs LD, Van Treuren T, Klinkebiel DL, Vishwanatha JK. PMID: 27589566.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Mol Cancer. 2015 Aug 15; 14:156. Kpetemey M, Dasgupta S, Rajendiran S, Das S, Gibbs LD, Shetty P, Gryczynski Z, Vishwanatha JK. PMID: 26272794.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    7. MIEN1 promotes oral cancer progression and implicates poor overall survival. Cancer Biol Ther. 2015; 16(6):876-85. Rajendiran S, Kpetemey M, Maji S, Gibbs LD, Dasgupta S, Mantsch R, Hare RJ, Vishwanatha JK. PMID: 25996585.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    8. Breast cancer disparities: Frontline strategies, proceedings of the 7(th) annual texas conference on health disparities. J Carcinog. 2012; 11:16. Kpetemey M, Kashyap MV, Gibbs L, Vishwanatha JK. PMID: 23230393.
      View in: PubMed   Mentions: